Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Submitted by
admin
on February 16, 2015 - 11:59am
Source:
Mass Device
News Tags:
devices
Smith & Nephew
Michaelson Diagnostics
diagnostics
skin cancer
Headline:
Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Do Not Allow Advertisers to Use My Personal information
